Adipose triglyceride lipase regulates eicosanoid production in activated human mast cells

Journal of Lipid Research

Volumn 55, Issue 12, 2014, Pages 2471-2478

  Dichlberger, Andrea ^a   Schlager, Stefanie ^a   Maaninka, Katariina ^a   Schneider, Wolfgang J ^b   Kovanen, Petri T ^a  

^a WIHURI RESEARCH INSTITUTE   (Finland)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Arachidonic acid; Leukotrienes; Lipid droplets; Lipolysis and fatty acid metabolism; Phospholipases A2; Prostaglandins

Indexed keywords

ADIPOSE TRIGLYCERIDE LIPASE; ARACHIDONIC ACID; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; FAT DROPLET; ICOSANOID; IMMUNOGLOBULIN E; LEUKOTRIENE C4; LIPID; PHOSPHOLIPASE A2; PROSTAGLANDIN G2; SMALL INTERFERING RNA; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG; CD34 ANTIGEN; CYTOSOLIC PHOSPHOLIPASE A2; PNPLA2 PROTEIN, HUMAN; PROSTAGLANDIN D2; PTGS1 PROTEIN, HUMAN; PTGS2 PROTEIN, HUMAN; TRIACYLGLYCEROL;

ADIPOSE TISSUE; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; EICOSANOID PRODUCTION; ENZYME ACTIVITY; ENZYME SUBSTRATE; FATTY ACID SYNTHESIS; GENE SILENCING; HUMAN; HUMAN CELL; HYDROLYSIS; LIPID HYDROLYSIS; MAST CELL; PROSTAGLANDIN RELEASE; ANTAGONISTS AND INHIBITORS; CELL CULTURE; CYTOLOGY; GENETICS; IMMUNOLOGY; KINETICS; LIPOLYSIS; METABOLISM; SECRETION (PROCESS);

ANTIGENS, CD34; ARACHIDONIC ACID; CELLS, CULTURED; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; EICOSANOIDS; GENE SILENCING; HUMANS; IMMUNOGLOBULIN E; KINETICS; LEUKOTRIENE C4; LIPASE; LIPID DROPLETS; LIPOLYSIS; MAST CELLS; PHOSPHOLIPASES A2, CYTOSOLIC; PROSTAGLANDIN D2; RNA, SMALL INTERFERING; TRIGLYCERIDES;

EID: 84919752982     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M048553     Document Type: Article

References (31)

1. Galli, S. J., and M. Tsai. 2012. IgE and mast cells in allergic disease. Nat. Med. 18: 693-704.
2. Anand, P., B. Singh, A. S. Jaggi, and N. Singh. 2012. Mast cells: an expanding pathophysiological role from allergy to other disorders. Naunyn Schmiedebergs Arch. Pharmacol. 385: 657-670.
3. Kovanen, P. T. 2007. Mast cells: multipotent local effector cells in atherothrombosis. Immunol. Rev. 217: 105-122.
4. Theoharides, T. C., D. Kempuraj, M. Tagen, P. Conti, and D. Kalogeromitros. 2007. Differential release of mast cell mediators and the pathogenesis of inflammation. Immunol. Rev. 217: 65-78.
5. Boyce, J. A. 2007. Mast cells and eicosanoid mediators: a system of reciprocal paracrine and autocrine regulation. Immunol. Rev. 217: 168-185.
6. Murakami, M., Y. Taketomi, Y. Miki, H. Sato, T. Hirabayashi, and K. Yamamoto. 2011. Recent progress in phospholipase A(2) research: from cells to animals to humans. Prog. Lipid Res. 50: 152-192.
7. Dvorak, A. M., H. F. Dvorak, S. P. Peters, E. S. Shulman, D. W. MacGlashan, Jr., K. Pyne, V. S. Harvey, S. J. Galli, and L. M. Lichtenstein. 1983. Lipid bodies: cytoplasmic organelles important to arachidonate metabolism in macrophages and mast cells. J. Immunol. 131: 2965-2976.
8. Triggiani, M., A. Oriente, M. C. Seeds, D. A. Bass, G. Marone, and F. H. Chilton. 1995. Migration of human inflammatory cells into the lung results in the remodeling of arachidonic acid into a triglyceride pool. J. Exp. Med. 182: 1181-1190.
9. Dichlberger, A., S. Schlager, J. Lappalainen, R. Kakela, K. Hattula, S. J. Butcher, W. J. Schneider, and P. T. Kovanen. 2011. Lipid body formation during maturation of human mast cells. J. Lipid Res. 52: 2198-2208.
10. Dichlberger, A., P. T. Kovanen, and W. J. Schneider. 2013. Mast cells: from lipid droplets to lipid mediators. Clin. Sci. (Lond.). 125: 121-130.
11. Funk, C. D. 2001. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science. 294: 1871-1875.
12. Dvorak, A. M. 2005. Mast cell secretory granules and lipid bodies contain the necessary machinery important for the in situ synthesis of proteins. Chem. Immunol. Allergy. 85: 252-315.
13. Zimmermann, R., J. G. Strauss, G. Haemmerle, G. Schoiswohl, R. Birner-Gruenberger, M. Riederer, A. Lass, G. Neuberger, F. Eisenhaber, A. Hermetter, et al. 2004. Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase. Science. 306: 1383-1386.
14. Zechner, R., P. C. Kienesberger, G. Haemmerle, R. Zimmermann, and A. Lass. 2009. Adipose triglyceride lipase and the lipolytic catabolism of cellular fat stores. J. Lipid Res. 50: 3-21.
15. Chandak, P. G., B. Radovic, E. Aflaki, D. Kolb, M. Buchebner, E. Frohlich, C. Magnes, F. Sinner, G. Haemmerle, R. Zechner, et al. 2010. Efficient phagocytosis requires triacylglycerol hydrolysis by adipose triglyceride lipase. J. Biol. Chem. 285: 20192-20201.
16. Radovic, B., E. Aflaki, and D. Kratky. 2012. Adipose triglyceride lipase in immune response, inflammation, and atherosclerosis. Biol. Chem. 393: 1005-1011.
17. Maaninka, K., J. Lappalainen, and P. T. Kovanen. 2013. Human mast cells arise from a common circulating progenitor. J. Allergy Clin. Immunol. 132: 463-469.e3.
18. Livak, K. J., and T. D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25: 402-408.
19. Dubois, R. N., S. B. Abramson, L. Crofford, R. A. Gupta, L. S. Simon, L. B. Van De Putte, and P. E. Lipsky. 1998. Cyclooxygenase in biology and disease. FASEB J. 12: 1063-1073.
20. Steinberg, G. R., B. E. Kemp, and M. J. Watt. 2007. Adipocyte triglyceride lipase expression in human obesity. Am. J. Physiol. Endocrinol. Metab. 293: E958-E964.
21. Lass, A., R. Zimmermann, M. Oberer, and R. Zechner. 2011. Lipolysis-a highly regulated multi-enzyme complex mediates the catabolism of cellular fat stores. Prog. Lipid Res. 50: 14-27.
22. Eichmann, T. O., M. Kumari, J. T. Haas, R. V. Farese, Jr., R. Zimmermann, A. Lass, and R. Zechner. 2012. Studies on the substrate and stereo/regioselectivity of adipose triglyceride lipase, hormone-sensitive lipase, and diacylglycerol-O-acyltransferases. J. Biol. Chem. 287: 41446-41457.
23. Campagna, F., L. Nanni, F. Quagliarini, E. Pennisi, C. Michailidis, F. Pierelli, C. Bruno, C. Casali, S. DiMauro, and M. Arca. 2008. Novel mutations in the adipose triglyceride lipase gene causing neutral lipid storage disease with myopathy. Biochem. Biophys. Res. Commun. 377: 843-846.
24. Kobayashi, K., T. Inoguchi, Y. Maeda, N. Nakashima, A. Kuwano, E. Eto, N. Ueno, S. Sasaki, F. Sawada, M. Fujii, et al. 2008. The lack of the C-terminal domain of adipose triglyceride lipase causes neutral lipid storage disease through impaired interactions with lipid droplets. J. Clin. Endocrinol. Metab. 93: 2877-2884.
25. Tavian, D., S. Missaglia, C. Redaelli, E. M. Pennisi, G. Invernici, R. Wessalowski, R. Maiwald, M. Arca, and R. A. Coleman. 2012. Contribution of novel ATGL missense mutations to the clinical phenotype of NLSD-M: a strikingly low amount of lipase activity may preserve cardiac function. Hum. Mol. Genet. 21: 5318-5328.
26. Kawata, R., S. T. Reddy, B. Wolner, and H. R. Herschman. 1995. Prostaglandin synthase 1 and prostaglandin synthase 2 both participate in activation-induced prostaglandin D2 production in mast cells. J. Immunol. 155: 818-825.
27. Ghosh, M., D. E. Tucker, S. A. Burchett, and C. C. Leslie. 2006. Properties of the Group IV phospholipase A2 family. Prog. Lipid Res. 45: 487-510.
28. Bozza, P. T., I. Bakker-Abreu, R. A. Navarro-Xavier, and C. Bandeira-Melo. 2011. Lipid body function in eicosanoid synthesis: an update. Prostaglandins Leukot. Essent. Fatty Acids. 85: 205-213.
29. Fujishima, H., R. O. Sanchez Mejia, C. O. Bingham III, B. K. Lam, A. Sapirstein, J. V. Bonventre, K. F. Austen, and J. P. Arm. 1999. Cytosolic phospholipase A2 is essential for both the immediate and the delayed phases of eicosanoid generation in mouse bone marrow-derived mast cells. Proc. Natl. Acad. Sci. USA. 96: 4803-4807.
30. Araújo-Santos, T., D. B. Prates, B. B. Andrade, D. O. Nascimento, J. Clarêncio, P. F. Entringer, A. B. Carneiro, M. A. Silva-Neto, J. C. Miranda, C. I. Brodskyn, et al. 2010. Lutzomyia longipalpis saliva triggers lipid body formation and prostaglandin E(2) production in murine macrophages. PLoS Negl. Trop. Dis. 4: e873.
31. Bozza, P. T., W. Yu, J. F. Penrose, E. S. Morgan, A. M. Dvorak, and P. F. Weller. 1997. Eosinophil lipid bodies: specific, inducible intracellular sites for enhanced eicosanoid formation. J. Exp. Med. 186: 909-920.